There was a slight but significant elevation of glutamic oxaloacetic transaminase (GOT) and glutamic pyruvic transaminase (GPT) in the COVID-19 group compared to non-COVID-19 patients (p < 0.01 and 0.03, respectively) (Table 2). Here, GPT is linked to COVID-19.